Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy

Kohei Shitara, Keitaro Matsuo, Seiji Ito, Akira Sawaki, Hiroki Kawai, Tomoya Yokota, Daisuke Takahari, Takashi Shibata, Takashi Ura, Hidemi Ito, Satoyo Hosono, Takakazu Kawase, Miki Watanabe, Kazuo Tajima, Yasushi Yatabe, Hideo Tanaka, Kei Muro

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Objective: Tumor cells that overexpress P-glycoprotein (Pgp) may be resistant to several anticancer agents due to altered pharmacokinetics and reduced intracellular concentrations of the anticancer agents. Pgp is encoded by the ATP binding cassette gene B1 (ABCB1). To our knowledge, only one previous report has evaluated the effect of ABCB1 gene polymorphisms on clinical outcomes of gastric cancer. The purpose of this analysis was to evaluate the impact of genetic polymorphisms of the ABCB1 gene on clinical outcomes in patients with advanced gastric cancer (AGC) treated with second-line chemotherapy. Methods: We retrospectively analyzed the impact of ABCB1 gene polymorphisms (ABCB1 3435C>T) on clinical outcomes in 100 patients with AGC who received second-line chemotherapy. Results: Median overall survival (OS) since the initiation of second-line chemotherapy was 6.0 months (95% confidence interval [CI], 4.8 to 8.0 months), and median progression-free survival (PFS) was 2.7 months (95% CI, 2.1 to 3.4 months). In a multivariate analysis of PFS, a 3435 CC polymorphism (n = 45) was significantly associated with longer PFS compared with the CT/TT type polymorphism (n = 55), with borderline significance (PFS of 3.2 months vs. 2.2 months, respectively; HR 1.50; 95% CI, 0.98-2.30; P = 0.061). ABCB1 3435 C>T polymorphisms were not associated with OS. No interaction was seen between ABCB1 polymorphisms and treatment regimens. Conclusion: Genetic polymorphisms of ABCB1 3435C>T might have a possible impact on clinical outcomes of second-line chemotherapy in AGC. Further prospective evaluation using a larger sample size is required.

Original languageEnglish
Pages (from-to)447-452
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume11
Issue number2
Publication statusPublished - 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Fingerprint

Dive into the research topics of 'Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy'. Together they form a unique fingerprint.

Cite this